Deborah Slee

About

Dr. Slee currently serves as the Vice President of Research & Development of ACTUS Biotechnologies and its two subsidiaries, Convoy Therapeutics, Inc. and EnduRx Pharmaceuticals, Inc. Dr. Slee has over two decades of experience in research and development in the biotechnology and pharmaceutical sectors. Dr. Slee began her career at Ontogen Corporation, followed by Neurocrine Biosciences and subsequently co-founded Aspyrian Therapeutics and CendR Therapeutics. Dr. Slee completed her Ph.D. at the University of Exeter and performed her postdoctoral research at The Scripps Research Institute in La Jolla, CA.

Investment Focus

Location

San Diego, US